Tonegawa made landmark discoveries about how the immune system generates antibody diversity and how the brain forms memories.
A blood test may predict if apparently healthy older adults are likely to develop Alzheimer’s symptoms in the next five or 10 years, researchers reported Wednesday.
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual will develop cognitive impairment—a key symptom of Alzheimer’s disease.
Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect 200 million people worldwide and represent the leading causes of visual impairment and blindness.
The Martin-Hopkins equation to assess low-density lipoprotein (LDL) cholesterol levels in blood samples has been used by laboratories in the U.S. and other countries to guide efforts to lower cardiovascular disease risk. Now, a simplified machine-learning version of this equation has been shown in a study of millions of U.S. adult and child blood samples to match the accuracy of the original—making it broadly accessible.
Researchers at the Technion Faculty of Biomedical Engineering have achieved a breakthrough in the early detection of heart failure.
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of Virginia Comprehensive Cancer Center research reveals. The findings could open the door to new ways to prevent breast cancer metastasis (spread), improve patient outcomes and save lives.
While wearable health sensors are becoming increasingly common, current iterations are awkward to wear. For example, devices attached to the face can draw unwanted attention, increase self-consciousness and influence the signals users are trying to measure. However, recent research may have found a solution by introducing ultrathin sensors that cannot be seen by observers or felt by the wearer.
Prostate cancer is often resistant to immunotherapy, which harnesses a person’s immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy new life, improving its ability to unleash cancer-killing cells in laboratory studies.
Learn how mechanical stretching helped lab-grown vessels sprout and redirect new capillaries, a step toward keeping engineered tissues alive.